{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:54:08Z","timestamp":1784710448240,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.chest.2021.03.059","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T08:38:36Z","timestamp":1620722316000},"page":"1075-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Breast and Lung Effusion Survival Score Models"],"prefix":"10.1016","volume":"160","author":[{"given":"Sofia","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Martinez-Zayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula V.","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk H.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horiana B.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chest.2021.03.059_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMra1403503","article-title":"Pleural disease","volume":"378","author":"Feller-Kopman","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1843.2007.01154.x","article-title":"Diagnosis and management of malignant pleural effusions","volume":"13","author":"Heffner","year":"2008","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.chest.2021.03.059_bib3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1378\/chest.13-1908","article-title":"Quality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters","volume":"145","author":"Ost","year":"2014","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.chest.2021.03.059_bib4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs\u00a0talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib5","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2021.03.059_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs\u00a0talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2021.03.059_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jso.24168","article-title":"Prognostic factors in patients with malignant pleural effusion: is it possible to predict mortality in patients with good performance status?","volume":"113","author":"Abrao","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.chest.2021.03.059_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000356764","article-title":"Prognostic factors in patients presenting with pleural effusion revealing malignancy","volume":"87","author":"Anevlavis","year":"2014","journal-title":"Respiration"},{"issue":"12","key":"10.1016\/j.chest.2021.03.059_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2021.03.059_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/crj.12292","article-title":"Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions","volume":"10","author":"Kasapoglu","year":"2016","journal-title":"Clin Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12885-017-3550-8","article-title":"Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.chest.2021.03.059_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.chest.2021.03.059_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"Bibby","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.chest.2021.03.059_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618785098","article-title":"Contemporary best practice in the management of malignant pleural effusion","volume":"12","author":"Koegelenberg","year":"2018","journal-title":"Ther Adv Respir Dis"},{"issue":"4","key":"10.1016\/j.chest.2021.03.059_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000491678","article-title":"Is the LENT score already outdated?","volume":"96","author":"Rozman","year":"2018","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.chest.2021.03.059_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1513\/AnnalsATS.201610-785OC","article-title":"Indwelling pleural catheters for patients with hematologic malignancies. A 14-year, single-center experience","volume":"14","author":"Faiz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"suppl 2","key":"10.1016\/j.chest.2021.03.059_bib20","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"issue":"5 suppl","key":"10.1016\/j.chest.2021.03.059_bib21","doi-asserted-by":"crossref","first-page":"e455S","DOI":"10.1378\/chest.12-2366","article-title":"Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Simoff","year":"2013","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2021.03.059_bib22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.03.059_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM Classification of Lung Cancer","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/resp.13362","article-title":"Risk factors for pleural effusion recurrence in patients with malignancy","volume":"24","author":"Grosu","year":"2019","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2009.09.012","article-title":"Predictors of mortality within three months in the patients with malignant pleural effusion","volume":"21","author":"\u00d6zyurtkan","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.chest.2021.03.059_bib26","series-title":"Epidemiology: An Introduction","author":"Rothman","year":"2012"},{"issue":"6","key":"10.1016\/j.chest.2021.03.059_bib27","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.chest.2021.03.059_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjc.6601117","article-title":"Survival analysis part IV: further concepts and methods in survival analysis","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.chest.2021.03.059_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1536867X0600600304","article-title":"Graphical representation of interactions","volume":"6","author":"Barthel","year":"2006","journal-title":"Stata Journal"},{"key":"10.1016\/j.chest.2021.03.059_bib30","author":"Guo"},{"issue":"2","key":"10.1016\/j.chest.2021.03.059_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10985-015-9330-3","article-title":"Estimating the concordance probability in a survival analysis with a discrete number of risk groups","volume":"22","author":"Heller","year":"2016","journal-title":"Lifetime Data Anal"},{"issue":"3","key":"10.1016\/j.chest.2021.03.059_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1536867X0600600302","article-title":"Confidence intervals for rank statistics: Somers\u2019 D and extensions","volume":"6","author":"Newson","year":"2006","journal-title":"Stata Journal"},{"key":"10.1016\/j.chest.2021.03.059_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1536867X1001000303","article-title":"Comparing the predictive powers of survival models using Harrell\u2019s C or Somers\u2019 D","volume":"10","author":"Newson","year":"2010","journal-title":"Stata Journal"},{"issue":"4","key":"10.1016\/j.chest.2021.03.059_bib34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1536867X1401400403","article-title":"Tools for checking calibration of a Cox model in external validation: approach based on individual event probabilities","volume":"14","author":"Royston","year":"2014","journal-title":"Stata Journal"},{"key":"10.1016\/j.chest.2021.03.059_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11864-019-0698-2","article-title":"Prognosticating for adult patients with advanced incurable cancer: a needed oncologist skill","volume":"21","author":"Chu","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.chest.2021.03.059_bib37","series-title":"StataCorp. Stata statistical software: release 14 [computer program]","year":"2015"},{"key":"10.1016\/j.chest.2021.03.059_bib38","series-title":"R: a language and environment for statistical computing [computer program]","year":"2019"},{"issue":"1","key":"10.1016\/j.chest.2021.03.059_bib39","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2021.03.059_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.05.005","article-title":"Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies","volume":"58","author":"Mei","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.chest.2021.03.059_bib41","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.mayocp.2015.08.010","article-title":"Diagnosis and treatment of chronic myeloid leukemia in 2015","volume":"90","author":"Thompson","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"21","key":"10.1016\/j.chest.2021.03.059_bib42","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1001\/jama.2014.14553","article-title":"Chronic lymphocytic leukemia: a clinical review","volume":"312","author":"Nabhan","year":"2014","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.chest.2021.03.059_bib43","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs\u00a0NSAIDs and larger vs\u00a0smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial","volume":"314","author":"Rahman","year":"2015","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.chest.2021.03.059_bib44","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs\u00a0chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.chest.2021.03.059_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2021.03.059_bib46","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.chest.2021.03.059_bib47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","article-title":"Prognostic significance of pleural fluid data in patients with malignant effusion","volume":"19","author":"Bielsa","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2021.03.059_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000489315","article-title":"An observational study evaluating the performance of LENT score in the selected population of malignant pleural effusion from lung adenocarcinoma in Singapore","volume":"96","author":"Abisheganaden","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.chest.2021.03.059_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jclinepi.2015.12.005","article-title":"A\u00a0calibration hierarchy for risk models was defined: from utopia to empirical data","volume":"74","author":"Van Calster","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.chest.2021.03.059_bib50","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1513\/AnnalsATS.201908-615OC","article-title":"Indwelling pleural catheter drainage strategy for malignant effusion: a cost-effectiveness analysis","volume":"17","author":"Shafiq","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.chest.2021.03.059_bib51","doi-asserted-by":"crossref","first-page":"e1102","DOI":"10.1634\/theoncologist.2018-0613","article-title":"Accuracy and prognostic significance of oncologists\u2019 estimates and scenarios for survival time in advanced gastric cancer","volume":"24","author":"Vasista","year":"2019","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.chest.2021.03.059_bib52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/jjco\/hyy080","article-title":"Comparison of the accuracy and characteristics of the prognostic prediction of survival of identical terminally ill cancer patients by oncologists and palliative care physicians","volume":"48","author":"Urahama","year":"2018","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.chest.2021.03.059_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpainsymman.2015.03.004","article-title":"The accuracy of physicians\u2019 clinical predictions of survival in patients with advanced cancer","volume":"50","author":"Amano","year":"2015","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.chest.2021.03.059_bib54","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpainsymman.2017.11.028","article-title":"A\u00a0Comparison of the accuracy of clinician prediction of survival versus the palliative prognostic index","volume":"55","author":"Farinholt","year":"2018","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.chest.2021.03.059_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221006760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221006760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:37:57Z","timestamp":1757925477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221006760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0012369221006760"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.03.059","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast and Lung Effusion Survival Score Models","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}